Here, we have fully tested and validated the use of a new, re-designed, and compact pyrosequencing platform, Pyromark Q48, for its applicability as a routine platform to detect the mutational status of three RAS genes (K-, N-, and H-RAS) in thyroid cancers. The gene discussed is HRAS; the disease is thyroid gland carcinoma.